Protocol
10-111
Full Title
Surviving Oropharynx Cancer: Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
Purpose
Some oropharynx (throat) cancers are related to the human papilloma virus (HPV). Throat cancers caused by HPV behave differently than those not caused by HPV. Researchers want to determine if there are differences in quality of life between patients whose cancers are caused by HPV and those who cancers are not caused by this virus. They believe that patients with these two different types of throat cancer will also have different experiences after completing therapy.
The long-term goal of this study is to see what symptoms most patients have after treatment has been completed. Patients will be asked to complete a survey about their symptoms and quality of life after completing therapy. The findings may help healthcare professionals learn how to improve post-treatment symptoms in people with throat cancer.
Investigator
Eligibility
To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have been treated for squamous cell carcinoma of the oropharynx at least one but no more than five years before entering the study. At least one component of treatment must have been received at Memorial Sloan-Kettering.
- Patients who had radiation therapy must have had this treatment at Memorial Sloan-Kettering.
- The HPV status of the patient’s tumor must be known or tumor tissue must be available for testing.
- Patients must be able to read and speak English.
- Patients must be age 18 or older.
For more information about this study, please contact Dr. David Pfister at 646-888-4232.
Disease(s)
Head & Neck Cancer
Survivorship
Locations
ClinicalTrials.gov
Related Diseases
